Uzm. Dr. Aysun Arslantaş Erken
Is this your profile? Claim it and verify your details.
Claim profileTrust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRadiation Oncologysaglik.gov.trFrom source
- Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
- Publications11 publicationsORCID, OpenAlexFrom source
- ORCID0000-0001-7101-3499ORCIDFrom source
- Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563460/doktorlarimiz.html#aysun-arslantas-erkensaglik.gov.tr
Scientific work
Publications
-
Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications
Asia-Pacific Journal of Clinical Oncology, 2026
DOI 10.1111/ajco.70119 PMID 42056758 Source: ORCID
-
Real‐World Outcomes of Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiotherapy in Stage II–III Locally Advanced Rectal Cancer: A Comparative Cohort Study
Asia-Pacific Journal of Clinical Oncology, 2026
DOI 10.1111/ajco.70118 PMID 42015370 Source: ORCID
-
Kemoterapi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045.c4306 Source: ORCID
-
Radyoterapi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045.c4305 Source: ORCID
-
Hasta ve Yakınları için Onkoloji Rehberi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045 Source: OpenAlex
-
Stereotactic radiotherapy for adrenal metastases: a multi-institutional review of patient characteristics and outcomes. Turkish Society for Radiation Oncology SBRT Group Study (TROD SBRT 10-004)
Oncology Research and Treatment, 2022
DOI 10.1159/000527052 PMID 36116432 5 citations (Europe PMC) Source: ORCID
-
Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)
Research Square, 2022
DOI 10.21203/rs.3.rs-1356246/v1 Open-access full textSource: OpenAlex
-
PO-1440 Multi-institutional review of SBRT for adrenal metastasis: Turkish Radiation Oncology Society Study
Radiotherapy and Oncology, 2022
DOI 10.1016/s0167-8140(22)03404-1 Source: OpenAlex
-
Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)
Research Square, 2022
DOI 10.21203/rs.3.rs-1356246/v2 Open-access full textSource: OpenAlex
-
Extreme hypofractionated radiosurgery in recurrent inoperable High-Grade Ultra-Large gliomas
International Journal of Radiation Research, 2022
Source: ORCID